1. Home
  2. KALV vs GHM Comparison

KALV vs GHM Comparison

Compare KALV & GHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • GHM
  • Stock Information
  • Founded
  • KALV N/A
  • GHM 1936
  • Country
  • KALV United States
  • GHM United States
  • Employees
  • KALV N/A
  • GHM N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • GHM Industrial Machinery/Components
  • Sector
  • KALV Health Care
  • GHM Industrials
  • Exchange
  • KALV Nasdaq
  • GHM Nasdaq
  • Market Cap
  • KALV 642.3M
  • GHM 527.6M
  • IPO Year
  • KALV N/A
  • GHM N/A
  • Fundamental
  • Price
  • KALV $14.31
  • GHM $50.90
  • Analyst Decision
  • KALV Strong Buy
  • GHM Strong Buy
  • Analyst Count
  • KALV 9
  • GHM 2
  • Target Price
  • KALV $26.29
  • GHM $60.00
  • AVG Volume (30 Days)
  • KALV 2.0M
  • GHM 122.9K
  • Earning Date
  • KALV 07-10-2025
  • GHM 08-06-2025
  • Dividend Yield
  • KALV N/A
  • GHM N/A
  • EPS Growth
  • KALV N/A
  • GHM 164.29
  • EPS
  • KALV N/A
  • GHM 1.11
  • Revenue
  • KALV N/A
  • GHM $209,896,000.00
  • Revenue This Year
  • KALV N/A
  • GHM $10.67
  • Revenue Next Year
  • KALV $347.19
  • GHM $9.35
  • P/E Ratio
  • KALV N/A
  • GHM $45.54
  • Revenue Growth
  • KALV N/A
  • GHM 13.13
  • 52 Week Low
  • KALV $7.30
  • GHM $24.78
  • 52 Week High
  • KALV $16.32
  • GHM $53.85
  • Technical
  • Relative Strength Index (RSI)
  • KALV 58.58
  • GHM 63.92
  • Support Level
  • KALV $11.10
  • GHM $48.48
  • Resistance Level
  • KALV $16.32
  • GHM $53.85
  • Average True Range (ATR)
  • KALV 1.10
  • GHM 2.03
  • MACD
  • KALV 0.36
  • GHM -0.20
  • Stochastic Oscillator
  • KALV 68.95
  • GHM 66.67

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About GHM Graham Corporation

Graham Corporation designs and manufactures mission-critical fluid, power, heat transfer, and vacuum technologies for the defense, space, energy, and process industries. The company also services and sells spare parts for its equipment. It designs and manufactures custom-engineered vacuum, heat transfer, cryogenic pump and turbomachinery technologies.

Share on Social Networks: